Literature DB >> 25872600

Incidence and Risk Factors for Tuberculosis After Liver Transplantation in an Endemic Area: A Nationwide Population-Based Matched Cohort Study.

C-Y Chen1,2,3, C-J Liu2,3,4, J-Y Feng3,5,6, C-C Loong1,3, C Liu1,3, C-Y Hsia1,3, L-Y Hu2,7, N-C Lin1,3, Y-W Hu2,3,8, C-M Yeh9, T-J Chen2,3,9, C-C Yang2,3,10,11.   

Abstract

Morbidity and mortality from tuberculosis (TB) are high in Taiwan. We conducted a nationwide population-based matched cohort study using data retrieved from the Taiwan's National Health Insurance Research Database to determine the impact of TB after liver transplantation (LT). During 2000-2011, we identified 3202 liver transplant recipients and selected subjects from the general population matched for age, sex, and comorbidities on the same index date of recognition of LT with a 1:10 ratio. The data were analyzed using Cox proportional hazards models. Compared to the matched cohort, liver transplant patients had a higher risk for TB (adjusted HR 2.25, 95% CI 1.65-3.05, p < 0.001), and those with TB showed higher mortality (HR 2.27, 95% CI 1.30-3.97, p = 0.004). Old age (HR 2.64, 95% CI 1.25-5.54, p = 0.011) and mammalian target of rapamycin inhibitors (mTORis) (HR 3.09, 95% CI 1.68-5.69, p < 0.001) were significant risk factors for TB in LT; mTORis were also associated with mortality after adjusting for confounders (HR 2.13, 95% CI 1.73-2.62, p < 0.001). Therefore, regular surveillance of TB and treatment of latent TB infection in high-risk patients after LT are important, especially in TB-endemic areas. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research / practice; epidemiology; health services and outcomes research; infection; infectious disease; liver disease: infectious; liver transplantation / hepatology; mycobacterial: tuberculosis; risk assessment / risk stratification; survey

Mesh:

Year:  2015        PMID: 25872600     DOI: 10.1111/ajt.13235

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  5 in total

1.  Diagnostic delay and mortality of active tuberculosis in patients after kidney transplantation in a tertiary care hospital in China.

Authors:  Wei Wu; Meifang Yang; Min Xu; Cheng Ding; Yongtao Li; Kaijin Xu; Jifang Shen; Lanjuan Li
Journal:  PLoS One       Date:  2018-04-16       Impact factor: 3.240

2.  Premature birth carries a higher risk of nephrotic syndrome: a cohort study.

Authors:  Chih-Chia Chen; Tsung Yu; Hsin-Hsu Chou; Yuan-Yow Chiou; Pao-Lin Kuo
Journal:  Sci Rep       Date:  2021-10-19       Impact factor: 4.379

3.  Comparative analysis of the drug-drug interaction between immunosuppressants, safety and efficacy of rifabutin from rifampicin-based Anti-TB treatment in living donor liver transplant recipients with active tuberculosis.

Authors:  Yu-Chen Wang; Noruel Gerard Salvador; Chih-Che Lin; Chao-Chien Wu; Ting-Lung Lin; Wei-Feng Lee; Yi-Chia Chan; Chao-Long Chen; Jeffrey Samuel Co; Domelle Dave Encarnacion
Journal:  Biomed J       Date:  2020-09-04       Impact factor: 7.892

Review 4.  Tropical Infections in the Context of Kidney Transplantation in Latin America.

Authors:  Lúcio R Requião-Moura; Elizabeth De Francesco Daher; Cassio R Moreira Albino; Savio de Oliveira Brilhante; Geraldo Bezerra da Silva Junior; Silvana Daher Costa; Tainá Veras de Sandes-Freitas
Journal:  Am J Trop Med Hyg       Date:  2021-06-28       Impact factor: 3.707

5.  Clinical Outcomes of Tuberculosis in Recipients After Living Donor Liver Transplantation.

Authors:  Noruel Gerard A Salvador; Sin-Yong Wee; Chih-Che Lin; Chao-Chien Wu; Hung-I Lu; Ting-Lung Lin; Wei-Feng Lee; Yi-Chia Chan; Li-Man Lin; Chao-Long Chen
Journal:  Ann Transplant       Date:  2018-10-19       Impact factor: 1.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.